Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Hacke W, et al. Among authors: kwiatkowski t. Lancet. 2004 Mar 6;363(9411):768-74. doi: 10.1016/S0140-6736(04)15692-4. Lancet. 2004. PMID: 15016487
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.
Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Adams HP Jr, et al. Among authors: kwiatkowski t. Stroke. 1996 Sep;27(9):1711-8. Stroke. 1996. PMID: 8784157 No abstract available.
Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.
Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Adams HP Jr, et al. Among authors: kwiatkowski t. Circulation. 1996 Sep 1;94(5):1167-74. doi: 10.1161/01.cir.94.5.1167. Circulation. 1996. PMID: 8790069 No abstract available.
Hypertension and its treatment in the NINDS rt-PA Stroke Trial.
Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC, Broderick J, Kwiatkowski T, Lewandowski C, Haley EC, Marler JR, Tilley BC. Brott T, et al. Among authors: kwiatkowski t. Stroke. 1998 Aug;29(8):1504-9. doi: 10.1161/01.str.29.8.1504. Stroke. 1998. PMID: 9707184 Clinical Trial.
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC Jr, Lyden PD, Kothari R, Frankel M, Lewandowski CA, Libman R, Kwiatkowski T, Broderick JP, Marler JR, Corrigan J, Huff S, Mitsias P, Talati S, Tanne D. Grotta JC, et al. Among authors: kwiatkowski t. Stroke. 1999 Aug;30(8):1528-33. doi: 10.1161/01.str.30.8.1528. Stroke. 1999. PMID: 10436095 Clinical Trial.
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP. Marler JR, et al. Among authors: kwiatkowski tp. Neurology. 2000 Dec 12;55(11):1649-55. doi: 10.1212/wnl.55.11.1649. Neurology. 2000. PMID: 11113218 Clinical Trial.
Thrombolysis in patients with transient neurologic deficits.
Lyden P, Lu M, Kwiatkowski T, Frankel M, Levine S, Broderick J, Brott T; NINDS rt-PA Stroke Study Group. Lyden P, et al. Among authors: kwiatkowski t. Neurology. 2001 Dec 11;57(11):2125-8. doi: 10.1212/wnl.57.11.2125. Neurology. 2001. PMID: 11739841 Clinical Trial.
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T; National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski T, et al. Ann Emerg Med. 2005 Apr;45(4):377-84. doi: 10.1016/j.annemergmed.2004.06.021. Ann Emerg Med. 2005. PMID: 15795715 Clinical Trial.
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; CLEAR Trial Investigators. Pancioli AM, et al. Among authors: kwiatkowski t. Stroke. 2008 Dec;39(12):3268-76. doi: 10.1161/STROKEAHA.108.517656. Epub 2008 Sep 4. Stroke. 2008. PMID: 18772447 Free PMC article. Clinical Trial.
96 results